TME rearrangements in OS have been correlated with chemotherapy-resistant phenotypes [44], whereas a survival gene signature based on the expression of collagen genes Col3a1, Col4a1, and Col5a2 is correlated with glioblastoma and pancreatic cancer aggressiveness [45,46]. This evidence concerns the gene COL3A1 and familial pancreatic carcinoma.